The Association of the G8 Questionnaire with Treatment Side Effects and Unscheduled Care among Older Adults with Bladder Cancer

Presenter Information

Umma Fatema, MD, Thomas Jefferson UniversityFollow
Amman Bhasin, MD, Thomas Jefferson UniversityFollow
Michael Zimmerman, MD, Thomas Jefferson UniversityFollow
Julia Palecki, MD, Thomas Jefferson UniversityFollow
Kendall Ozorowski, Thomas Jefferson UniversityFollow
Kristine Swartz, MD, Thomas Jefferson UniversityFollow
Kevin Zarrabi, MD, Thomas Jefferson UniversityFollow
Kuang-Yi Wen, PhD, Thomas Jefferson UniversityFollow

Start Date

5-3-2024 9:10 AM

End Date

5-3-2024 11:00 AM

Description

Background

• The average age of people when they are diagnosed with bladder cancer is 73
• Bladder cancer in the geriatric population is often complicated by the presence of comorbidities and this population is at increased risk of experiencing short-term and long-term toxicities
• This necessitates a multimodal treatment approaches with a careful balance between efficacy and toxicity management
• The G8 questionnaire, a geriatric assessment tool, is designed to identify frailties and health risks in older patients, guiding healthcare professionals in tailoring treatment
• The aim of the study is to determine the predictive value of the G8 scores for adverse treatment outcomes in older patients with bladder cancer

Keywords

bladder cancer, geriatric, G8 questionnaire, chemotherapy, cystectomy

Comments

Presented at the 2024 Jefferson Health Equity and Quality Improvement (HEQI) Summit.